|Study Description:||The goal of this clinical research study is to learn about the safety and |
effectiveness of brentuximab vedotin given before and after standard
chemotherapy called CHOP (cyclophosphamide, doxorubicin, vincristine, and
prednisone) and brentuximab vedotin given with and after a chemotherapy called
CH-P (cyclophosphamide, doxorubicin, and prednisone) in patients with ALCL.
Researchers also want to learn the highest tolerable dose of brentuximab
vedotin that can be given in combination with CH-P chemotherapy.